Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Mutational landscape of risk variants in comorbid depression and obesity: a next-generation sequencing approach

  • Pérez-Gutiérrez, Ana María
  • Carmona, Rosario
  • Loucera, Carlos
  • Cervilla Ballesteros, Jorge Antonio|||0000-0001-6891-1992
  • Gutiérrez Martínez, Blanca|||0000-0002-2750-8440
  • Molina Rivas, Esther|||0000-0002-0771-7608
  • López-López, Daniel
  • Pérez-Florido, Javier
  • Zarza Rebollo, Juan Antonio
  • López Isac, Elena
  • Dopazo, Joaquín
  • Martínez González, Luis Javier
  • Rivera Sánchez, Margarita|||0000-0003-4717-1045
This study was partially funded by Consejería de Salud, Junta de Andalucía (PI322-2009), Consejería de Innovación, Proyecto de Excelencia (CTS-2010-6682), Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union (PI18/00238 and PI23/00201), FEDER/Junta de Andalucía (B-CTS-256-UGR20), the Marie Curie research Grants Scheme (FP7-626235) and by a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (22514). AMPG was supported by a grant from the Ministry of Economy and Competitiveness and Institute of Health Carlos III (FI19/00228). ELI received financial support from the Spanish Ministry of Science and Innovation Juan de la Cierva Incorporación Program (grant code IJC2019-040080-I/AEI/10.13039/501100011033) and Ramon y Cajal Program (RYC2021-034816-I). RC was supported by a Postdoctoral Grant RH-0052-2021 from Junta de Andalucía and co-funded by the European Union, European Social Fund (FSE) 2014–2020., Major depression (MD) and obesity are complex genetic disorders that are frequently comorbid. However, the study of both diseases concurrently remains poorly addressed and therefore the underlying genetic mechanisms involved in this comorbidity remain largely unknown. Here we examine the contribution of common and rare variants to this comorbidity through a next-generation sequencing (NGS) approach. Specific genomic regions of interest in MD and obesity were sequenced in a group of 654 individuals from the PISMA-ep epidemiological study. We obtained variants across the entire frequency spectrum and assessed their association with comorbid MD and obesity, both at variant and gene levels. We identified 55 independent common variants and a burden of rare variants in 4 genes (PARK2, FGF21, HIST1H3D and RSRC1) associated with the comorbid phenotype. Follow-up analyses revealed significantly enriched gene-sets associated with biological processes and pathways involved in metabolic dysregulation, hormone signaling and cell cycle regulation. Our results suggest that, while risk variants specific to the comorbid phenotype have been identified, the genes functionally impacted by the risk variants share cell biological processes and signaling pathways with MD and obesity phenotypes separately. To the best of our knowledge, this is the first study involving a targeted sequencing approach toward the study of the comorbid MD and obesity. The framework presented here allowed a deep characterization of the genetics of the co-occurring MD and obesity, revealing insights into the mutational and functional profile that underlies this comorbidity and contributing to a better understanding of the relationship between these two disabling disorders., Junta de Andalucía PI322-2009, B-CTS-256-UGR20, RH-0052-2021, Consejería de Innovación, Proyecto de Excelencia (CTS-2010-6682), Instituto de Salud Carlos III (ISCIII), European Union (PI18/00238, PI23/00201), FEDER, Marie Curie research Grants Scheme (FP7-626235), Brain & Behavior Research Foundation (22514), Ministry of Economy and Competitiveness (FI19/00228), Spanish Ministry of Science and Innovation IJC2019-040080-I/AEI/10.13039/501100011033, RYC2021-034816-I, European Union, European Social Fund (FSE) 2014–2020
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Interaction Effect between Physical Activity and the BDNF Val66Met Polymorphism on Depression in Women from the PISMA-ep Study

  • Zarza Rebollo, Juan Antonio
  • Molina Rivas, Esther|||0000-0002-0771-7608
  • López Isac, Elena
  • Pérez Gutiérrez, Ana María
  • Gutiérrez Martínez, Blanca|||0000-0002-2750-8440
  • Cervilla Ballesteros, Jorge Antonio|||0000-0001-6891-1992
  • Rivera Sánchez, Margarita|||0000-0003-4717-1045
This study was partially funded by the Consejeria de Salud, Junta de Andalucia (PI3222009), Consejeria de Innovacion, Proyecto de Excelencia (CTS-2010-6682), the Institute of Health Carlos III (Co-funded by European Regional Development Fund/European Social Fund "A way to make Europe"/"Investing in your future") (projects PI18/00238 and PI18/00467), the Marie Curie Research Grants Scheme (FP7 626235), and by a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (22514). Juan Antonio Zarza-Rebollo was supported by the Spanish Ministry of Economy and Competitiveness (BES-2017-082698). Elena Lopez-Isac received financial support from the Spanish Ministry of Science and Innovation Juan de la Cierva Incorporacion Program (grant code IJC2019-040080-I/AEI/10.13039/501100011033). AnaMPerez-Gutierrez was supported by a grant from the Ministry of Economy and Competitiveness and Institute of Health Carlos III (FI19/00228), and Margarita Rivera was supported by the Ministry of Economy and Competitiveness Ramon y Cajal Program (RYC-2014-15774)., The relationship between depression and the Val66Met polymorphism at the brain-derived neurotrophic factor gene (BDNF), has been largely studied. It has also been related to physical activity, although the results remain inconclusive. The aim of this study is to investigate the relationship between this polymorphism, depression and physical activity in a thoroughly characterised sample of community-based individuals from the PISMA-ep study. A total of 3123 participants from the PISMAep study were genotyped for the BDNF Val66Met polymorphism, of which 209 had depression. Our results are in line with previous studies reporting a protective effect of physical activity on depression, specifically in light intensity. Interestingly, we report a gene-environment interaction effect in which Met allele carriers of the BDNF Val66Met polymorphism who reported more hours of physical activity showed a decreased prevalence of depression. This effect was observed in the total sample (OR = 0.95, 95%CI = 0.90–0.99, p = 0.027) and was strengthened in women (OR = 0.93, 95%CI = 0.87–0.98, p = 0.019). These results highlight the potential role of physical activity as a promising therapeutic strategy for preventing and adjuvant treatment of depression and suggest molecular and genetic particularities of depression between sexes., Junta de Andalucia PI3222009, Consejeria de Innovacion, Proyecto de Excelencia CTS-2010-6682, Institute of Health Carlos III (European Regional Development Fund/European Social Fund "A way to make Europe"/"Investing in your future") PI18/00238 PI18/00467, Marie Curie Research Grants Scheme FP7 626235, NARSAD 22514, Spanish Government BES-2017-082698, Spanish Ministry of Science and Innovation Juan de la Cierva Incorporacion Program IJC2019-040080-I/AEI/10.13039/501100011033, Ministry of Economy and Competitiveness, Instituto de Salud Carlos III FI19/00228, Ministry of Economy and Competitiveness Ramon y Cajal Program RYC-2014-15774
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mutational landscape of risk variants in comorbid depression and obesity: a next-generation sequencing approach

  • Pérez-Gutiérrez, Ana M.
  • Carmona, Rosario
  • Loucera, Carlos
  • Cervilla, Jorge A.
  • Gutiérrez, Blanca
  • Molina, Esther
  • López-López, Daniel
  • Pérez-Florido, Javier
  • Zarza-Rebollo, Juan Antonio
  • López-Isac, Elena
  • Dopazo, Joaquín
  • Martínez-González, Luis Javier
  • Rivera, Margarita
Major depression (MD) and obesity are complex genetic disorders that are frequently comorbid. However, the study of both diseases concurrently remains poorly addressed and therefore the underlying genetic mechanisms involved in this comorbidity remain largely unknown. Here we examine the contribution of common and rare variants to this comorbidity through a next-generation sequencing (NGS) approach. Specific genomic regions of interest in MD and obesity were sequenced in a group of 654 individuals from the PISMA-ep epidemiological study. We obtained variants across the entire frequency spectrum and assessed their association with comorbid MD and obesity, both at variant and gene levels. We identified 55 independent common variants and a burden of rare variants in 4 genes (PARK2, FGF21, HIST1H3D and RSRC1) associated with the comorbid phenotype. Follow-up analyses revealed significantly enriched gene-sets associated with biological processes and pathways involved in metabolic dysregulation, hormone signaling and cell cycle regulation. Our results suggest that, while risk variants specific to the comorbid phenotype have been identified, the genes functionally impacted by the risk variants share cell biological processes and signaling pathways with MD and obesity phenotypes separately. To the best of our knowledge, this is the first study involving a targeted sequencing approach toward the study of the comorbid MD and obesity. The framework presented here allowed a deep characterization of the genetics of the co-occurring MD and obesity, revealing insights into the mutational and functional profile that underlies this comorbidity and contributing to a better understanding of the relationship between these two disabling disorders., This study was partially funded by Consejería de Salud, Junta de Andalucía (PI322-2009), Consejería de Innovación, Proyecto de Excelencia (CTS-2010-6682), Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union (PI18/00238 and PI23/00201), FEDER/Junta de Andalucía (B-CTS-256-UGR20), the Marie Curie research Grants Scheme (FP7-626235) and by a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (22514). AMPG was supported by a grant from the Ministry of Economy and Competitiveness and Institute of Health Carlos III (FI19/00228). ELI received financial support from the Spanish Ministry of Science and Innovation Juan de la Cierva Incorporación Program (grant code IJC2019-040080-I/AEI/10.13039/501100011033) and Ramon y Cajal Program (RYC2021-034816-I). RC was supported by a Postdoctoral Grant RH-0052-2021 from Junta de Andalucía and co-funded by the European Union, European Social Fund (FSE) 2014–2020., Peer reviewed